CLINICAL TRIALS PROFILE FOR EPIRUBICIN HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for EPIRUBICIN HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002529 ↗ | Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer | Completed | International Breast Cancer Study Group | Phase 3 | 1993-05-01 | RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy may fight breast cancer by blocking the uptake of estrogen. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with hormone therapy may kill more tumor cells. It is not yet known which treatment regimen is more effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of hormone therapy during or after combination chemotherapy or hormone therapy alone in treating perimenopausal or postmenopausal women who have stage II or stage IIIA breast cancer. |
| NCT00002542 ↗ | Tamoxifen in Treating Women With High-Risk Breast Cancer | Completed | NCIC Clinical Trials Group | Phase 3 | 1993-07-20 | RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using tamoxifen may fight breast cancer by blocking the uptake of estrogen. Chemotherapy uses different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase III trial to study the effectiveness of tamoxifen following surgery and chemotherapy in treating women who have stage I breast cancer at high risk of recurrence or stage II or stage III breast cancer. |
| NCT00002544 ↗ | Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer | Completed | Arbeitsgemeinschaft fur Internistische Onkologie | Phase 3 | 1993-05-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if mitoxantrone is more effective with or without docetaxel. PURPOSE: Randomized phase III trial to compare the effectiveness of mitoxantrone with or without docetaxel in treating women who have metastatic breast cancer with a poor prognosis. |
| NCT00002615 ↗ | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | Completed | Medical Research Council | Phase 3 | 1994-06-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not known whether receiving chemotherapy before surgery may be more effective than surgery alone in treating patients with stomach cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery plus combination chemotherapy with surgery alone in treating patients with stomach cancer. |
| NCT00002784 ↗ | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer | Completed | International Breast Cancer Study Group | Phase 3 | 1996-06-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. It is not yet known if high-dose combination chemotherapy plus peripheral stem cell transplantation is more effective than standard combination chemotherapy for breast cancer. PURPOSE: Randomized phase III trial to compare high-dose combination chemotherapy plus peripheral stem cell transplantation with standard combination chemotherapy in treating women with stage II or stage III breast cancer. |
| NCT00002866 ↗ | Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer | Completed | NCIC Clinical Trials Group | Phase 1 | 1996-08-12 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as G-CSF may increase the number of immune cells found in bone marrow or peripheral blood and may help a person 's immune system recover from the side effects of chemotherapy. PURPOSE: Phase I/II trial to study the effectiveness of docetaxel and epirubicin with and without G-CSF in treating women with metastatic breast cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EPIRUBICIN HYDROCHLORIDE
Condition Name
Clinical Trial Locations for EPIRUBICIN HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for EPIRUBICIN HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for EPIRUBICIN HYDROCHLORIDE
Sponsor Name
